Politico July 20, 2023
By Ben Leonard
Gene therapy advocates say the treatments can cure rare diseases more quickly if government helps.
Therapies that change genes are spurring innovative treatments for intractable diseases.
The Food and Drug Administration has approved eight gene therapies in the past year and a half, including one last month to treat a rare muscular disorder. More are under review.
POLITICO invited experts, advocates and government leaders to a summit on Thursday to examine their promise and the barriers to access.
Here are the top takeaways:
Access remains an issue
Gene therapies can cost millions per dose and insurers and government health care programs have been slow to cover them, said Erica Cischke, vice president of government affairs at...
Topics: AI (Artificial Intelligence),
Biotechnology,
Conferences / Podcast,
Equity/SDOH,
FDA,
Govt Agencies,
Healthcare System,
Payment Models,
Pharma / Biotech,
Provider,
Technology,
Trends,
Value Based Related Articles: